New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development

被引:9
|
作者
Wu, Ming [1 ]
Yu, Shengqiang [1 ]
机构
[1] Second Mil Med Univ, Shanghai Changzheng Hosp, Kidney Inst PLA, Div Nephrol, 415 Fengyang Rd, Shanghai 200003, Peoples R China
基金
中国国家自然科学基金;
关键词
Polycystic kidney disease; Transporters; Channels; Molecular mechanism;
D O I
10.1159/000444839
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant polycystic kidney disease (PKD) or autosomal recessive PKD is caused by a mutation in the PKD1, PKD2 or PKHD1 gene, which encodes polycystin-1, polycystin-2 or fibrocystin, respectively. Embryonic and postnatal mutation studies show that transport or channel function is dysregulated before the initiation of cystogenesis, suggesting that the abnormality of transport or channel function plays a critical role in the pathology of PKD. Summary: Polycystin-2 by itself is a calcium-permeable cation channel, and its channel function can be regulated by polycystin-1 or fibrocystin. In this paper, we reviewed the current knowledge about calcium transports and cyclic adenosine monophosphate (cAMP)-driven chloride transports in PKD. In addition, the function and the underlining mechanism of glucose transporters, phosphate transporters and water channels in PKD are also discussed. Key Messages: Abnormalities in calcium handling and exuberant cAMP-dependent cystic fibrosis transmembrane conductance regulator-mediated fluid secretion in the collecting duct are the most important issues in the pathogenesis of PKD. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [21] New insights into the molecular mechanisms of Lafora disease
    Nature Clinical Practice Neurology, 2008, 4 (2): : 62 - 63
  • [22] Cellular and molecular mechanisms of dysferlinopathy: New insights
    Bloch, R. J.
    Ziman, A.
    Kerr, J.
    Ru, L.
    Resneck, W.
    Roche, J. A.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 750 - 750
  • [23] Molecular mechanisms of arterial stiffness: new insights
    Luft, Friedrich C.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2012, 6 (06) : 436 - 438
  • [24] New insights into molecular mechanisms of haematological malignancies
    Fey, M. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 59 - 62
  • [25] New insights into the molecular mechanisms of action of azathioprine
    Neurath, MF
    MECHANISMS OF INTESTINAL INFLAMMATION: IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN IBD, 2004, 133 : 187 - 194
  • [26] Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies
    Liang, Yongyi
    Qiu, Shaojun
    Zou, Youwen
    Luo, Lianxiang
    PHYTOMEDICINE, 2024, 122
  • [27] Targeting GIRK channels for the development of new therapeutic agents
    Walsh, Kenneth B.
    FRONTIERS IN PHARMACOLOGY, 2011, 2
  • [28] Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations
    Hedger, George
    Sansom, Mark S. P.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2016, 1858 (10): : 2390 - 2400
  • [29] tRNA-targeting ribonucleases: molecular mechanisms and insights into their physiological roles
    Ogawa, Tetsuhiro
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2016, 80 (06) : 1037 - 1045
  • [30] Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms
    Huang, Jian
    Korsunsky, Aron
    Yazdani, Mahdieh
    Chen, Jianhan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 16